Radial Data Visualization-Based Step-by-Step Eliminative Algorithm to Predict Colorectal Cancer Patients' Response to
Jakub Kryczka1, Rafał Adam Bachorz2, Jolanta Kryczka3
1Laboratory of Cell Signaling, Institute of Medical Biology, Polish Academy of Sciences, 106 Lodowa St., 93-232 Lodz, Poland.
International Journal of Molecular Sciences
|November 27, 2024
Summary
This study developed an algorithm to predict colorectal cancer (CRC) patient response to FOLFOX chemotherapy. The algorithm identifies key gene expression markers to guide treatment decisions and improve patient outcomes.
Area of Science:
- Oncology
- Genomics
- Bioinformatics
Background:
- Colorectal cancer (CRC) patients often develop chemo-resistance to FOLFOX treatment, leading to therapy failure.
- Predicting patient response to FOLFOX is crucial for effective treatment strategies.
Purpose of the Study:
- To develop a functional and user-friendly algorithm for predicting patient response to FOLFOX chemotherapy in CRC.
- To identify key gene expression markers associated with FOLFOX resistance.
Main Methods:
- Downloaded transcriptomic data from Gene Expression Omnibus (GEO) for CRC patients treated with FOLFOX.
- Analyzed gene expression differences between FOLFOX responders and non-responders to identify potential markers.
- Developed a step-by-step predictive algorithm using modified radial data visualization.
Main Results:
- Identified specific gene expression patterns in FOLFOX-resistant CRC samples, including upregulated TMEM182 and MCM9, and downregulated LRRFIP1.
- The developed algorithm, utilizing 14 gene markers, demonstrated capability in predicting FOLFOX therapy response.
- Highlighted the interplay of gene expression levels in predicting treatment outcomes.
Conclusions:
- The developed algorithm offers valuable insights for clinical decision-making in CRC treatment.
- Accurate prediction of FOLFOX response can potentially improve patient survival and reduce treatment-related futility.
- This approach aids in personalized therapy administration for colorectal cancer.


